The global neonatal thermoregulation market is estimated at US$ 661.8 million in 2023. The market is projected to reach US$ 1,151.6 million by 2033, exhibiting a CAGR of 5.7% from 2023 to 2033.
Growing awareness regarding neonatal care has been fuelling the sales of neonatal thermoregulation equipment suppliers around the world for the past decade, while the rise in demand from the hospitals sector is further catering to it. Despite getting temporarily declined during the outbreak of the deadly COVID-19 pandemic in 2020, the industry players are gaining momentum again with the steady recovery in key end-use sectors.
The latest revised report on the neonatal thermoregulation market by Future Market Insights (FMI) provides a detailed analysis of the global industry, growth & restraining factors, and demand-supply patterns during the forecast period of 2023 to 2033.
Future Market Insights anticipates that suppliers and manufacturers will target the leading regions such as North America, Europe, and Asia Pacific, while China, India, the United States, Japan, and a few others countries will remain highly lucrative throughout the forecast period.
| Attributes | Details |
|---|---|
| Neonatal Thermoregulation Market Value (2022) | US$ 627 million |
| Neonatal Thermoregulation Market Value (2023) | US$ 661.8 million |
| Neonatal Thermoregulation Market Expected Value (2033) | US$ 1,151.6 million |
| Neonatal Thermoregulation Market Projected CAGR (2023 to 2033) | 5.7% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
regarding neonates’ care has bolstered the growth of the neonatal thermoregulation industry in the past years. With the increase in birth rates, equipment required for newborns’ monitoring, and caring grew substantially over the past decade apart from facing temporary restraints due to the pandemic outbreak in 2020.
According to FMI, the overall industry outlook remained positive for neonatal thermoregulation equipment suppliers during the last 5 years from 2018 to 2022.
Requirement for proper thermoregulation to ensure newborns’ health and well-being is getting prominence in the hospital sector. Additionally, advancements in the neonatal and pediatric intensive care sectors are aiding the growth of stakeholders. According to FMI, the global neonatal thermoregulation industry is predicted to expand at over 5.7% CAGR through 2033.
Requirement for proper thermoregulation in order to ensure newborns’ health and wellbeing is getting prominence in hospitals sector. Additionally, advancements in neonatal and paediatric intensive care sector is aiding to the growth of stakeholders.
Neonatal thermoregulation solution is highly sought-after in hospitals industry in preventing heat loss and providing a stable thermal environment for neonates and infants. As a result, demand for neonatal thermoregulation equipment is growing fast from hospitals sector.
According to the report titled “Medical Technology Industry Spotlight” published by the SelectUSA, the United States is the largest hospital and medical devices industry in the world valued at US$ 156 Billion, which is 40% of the global industry as in 2017.
As per the report, the United States hospitals and medical devices industry is forecast to reach US$ 208 billion by 2023. These figures give a glimpse of the growing opportunities for neonatal thermoregulation equipment providers around the globe.
Principal Consultant
Despite playing an integral part in neonatal health and care, neonatal thermoregulation equipment suppliers often come across various restraining factors such as-
United State to Dominate the North American Market
The United States is the hotspot for neonatal thermoregulation industry players, being in the epicenter of the world’s largest industry North America. Highly advanced healthcare industry and rising awareness regarding deaths of newborns are boosting the growth of neonatal thermoregulation companies in the United States.
According to the report titled “Infant Mortality in the United States” published by the National Centre for Biotechnology Information (NCBI), the United States infant mortality rate was 5.79 infant deaths per 1,000 live births in 2017, not much different from the rate of 5.87 in 2016.
As per the report, the neonatal and post neonatal mortality rates for 2017 were 3.85 and 1.94 respectively, which were unchanged as compared with 2016. Such reports are boosting the awareness regarding neonatal healthcare, which in turn is fuelling the sales of neonatal thermoregulation equipment suppliers. The United States held a share of 18% in 2022.
High Expenditure to Lead to Major Market Growth in Germany
Germany has been contributing significantly to the demand growth in Europe neonatal thermoregulation industry, being in the focal point for stakeholders. Backed by the highly advanced manufacturing hubs and technically advanced hospitals sector, Germany is highly sought-after for neonatal thermoregulation manufactures.
As stated in the report titled “Healthcare Expenditure Statistics” published by the European Commission (EC), among the European Union (EU) member states, France, Germany, and Sweden had the highest healthcare expenditure relative to Gross Domestic Product (GDP) in 2017 (between 11.0% and 11.3%). This indirectly refers to the lucrative growth scope for neonatal thermoregulation industry players in Germany. Germany market is expected to grow at a CAGR of 3.7% over the coming decades.
China to Dominate the Asia Pacific Market
China is dominating in Asia Pacific neonatal thermoregulation industry and subject to exhibit hegemony during the forecast period. Increase in focus to reduce neonates’ mortality rate and governmental investments in healthcare and medical devices industry are spurring the growth of neonatal thermoregulation equipment suppliers in China.
As per the report titled “Neonatal Mortality in Hospitalized Chinese Population” published by the NCBI in 2019, in China, the mortality in neonates with a gestational age of 28-32 weeks (0.5.7%) was significantly higher than that of < 28 weeks, 32-37 weeks, 37-42 weeks, and >42 weeks as in 2019.
The report also stated that the neonatal mortality in Eastern China was lower than that of the Central and Western China, while the major causes of neonatal deaths included asphyxia, respiratory distress syndrome, and infection. These data explain well why suppliers of neonatal thermoregulation equipment are targeting China in order to excel in this field. China market is expected to grow at a CAGR of 6.3% over the coming decades.
Japan to Take the Limelight in the Industry
Japan has taken the limelight of neonatal thermoregulation equipment manufacturers due to having technically advanced paediatric and neonatal healthcare and intensive care sector and highly developed manufacturing infrastructure.
According to the report titled “Japan- Healthcare IT” published by the Japan Country Commercial Guide on 9th June, 2019, Japan continues to rank among the top export prospects according to the United States Department of Commerce’s Health IT top market report.
As stated in the report titled “Utilizing Artificial Intelligence (AI) in Healthcare Sector”, published by the Ministry of Health, Labor and Welfare’s artificial intelligence advisory panel in June, 2017, various new innovations and technologies including AI are being adopted in healthcare sector. This gives an idea regarding the new opportunities awaiting for neonatal thermoregulation industry players in Japan.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Highly efficient in controlling and maintaining proper temperature to Boost up The Segment Growth
Presently, various types of warmer such as radiant warmers and wall mount warmers are highly sought-after in the global neonatal thermoregulation industry. According to FMI, these segments will sustain in the positions in terms of product type, owing to have various exclusive properties such as-
Other key segments in terms of product type, which are catering to the growth of suppliers, are neonatal incubators and neonatal cooling systems.
High adoption of Open Modality Segment by Healthcare Professionals to Spur Market Growth
Currently, open modality is highly preferred by manufacturers as well as healthcare professionals in the neonatal thermoregulation industry. This type of modality is highly demanded owing to its various advantages such as-
As a result, the demand for neonatal thermo-regulators with open modality is forecast to rise further in the near future.
With the competition getting stricter each passing year, key industry players are emphasizing on bringing in diverse range of neonatal thermoregulation devices and equipment.
Some of the key players supplying neonatal thermoregulation equipment are-
| Attribute | Details |
|---|---|
| Forecast Period | 2023 to 2033 |
| Historical Data Available for | 2018 to 2022 |
| Market Analysis | US$ million for Value |
| Key Regions Covered |
|
| Key Countries Covered |
|
| Key Segments Covered |
|
| Key Companies Profiled |
|
| Customization & Pricing | Available upon Request |
The market is expected to reach US$ 661.8 million in 2023.
The market is anticipated to expand at a CAGR of 5.7%.
Upsurging awareness about neonatal care is yielding market expansion.
Costly installation and lack of expertise in handling the equipment are major factors pulling back the market growth.
Innovations in pediatric intensive care sector is a running trend in the market.
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Investment Feasibility Matrix
3.5. PESTLE and Porter’s Analysis
3.6. Regulatory Landscape
3.6.1. By Key Regions
3.6.2. By Key Countries
3.7. Regional Parent Market Outlook
4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033
4.1. Historical Market Size Value (US$ Million) Analysis, 2018 to 2022
4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product Type
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Million) Analysis By Product Type, 2018 to 2022
5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Product Type, 2023 to 2033
5.3.1. Warmer
5.3.1.1. Radiant Warmer
5.3.1.2. Wall Mount Warmer
5.3.2. Neonatal Incubators
5.3.2.1. Intensive Care Incubator
5.3.2.2. Transport Incubator
5.3.3. Neonatal Cooling Systems
5.4. Y-o-Y Growth Trend Analysis By Product Type, 2018 to 2022
5.5. Absolute $ Opportunity Analysis By Product Type, 2023 to 2033
6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Modality
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Million) Analysis By Modality, 2018 to 2022
6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Modality, 2023 to 2033
6.3.1. Open
6.3.2. Close
6.4. Y-o-Y Growth Trend Analysis By Modality, 2018 to 2022
6.5. Absolute $ Opportunity Analysis By Modality, 2023 to 2033
7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ Million) Analysis By End User , 2018 to 2022
7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End User , 2023 to 2033
7.3.1. Hospitals
7.3.2. Paediatric and Neonatal
7.3.2.1. Intensive Care Units
7.3.3. Others
7.4. Y-o-Y Growth Trend Analysis By End User , 2018 to 2022
7.5. Absolute $ Opportunity Analysis By End User , 2023 to 2033
8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region
8.1. Introduction
8.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018 to 2022
8.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. South Asia
8.3.5. East Asia
8.3.6. Oceania
8.3.7. MEA
8.4. Market Attractiveness Analysis By Region
9. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
9.2.1. By Country
9.2.1.1. The USA
9.2.1.2. Canada
9.2.2. By Product Type
9.2.3. By Modality
9.2.4. By End User
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Product Type
9.3.3. By Modality
9.3.4. By End User
9.4. Key Takeaways
10. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
10.2.1. By Country
10.2.1.1. Brazil
10.2.1.2. Mexico
10.2.1.3. Rest of Latin America
10.2.2. By Product Type
10.2.3. By Modality
10.2.4. By End User
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Product Type
10.3.3. By Modality
10.3.4. By End User
10.4. Key Takeaways
11. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
11.2.1. By Country
11.2.1.1. Germany
11.2.1.2. United Kingdom
11.2.1.3. France
11.2.1.4. Spain
11.2.1.5. Italy
11.2.1.6. Rest of Europe
11.2.2. By Product Type
11.2.3. By Modality
11.2.4. By End User
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Product Type
11.3.3. By Modality
11.3.4. By End User
11.4. Key Takeaways
12. South Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
12.2.1. By Country
12.2.1.1. India
12.2.1.2. Malaysia
12.2.1.3. Singapore
12.2.1.4. Thailand
12.2.1.5. Rest of South Asia
12.2.2. By Product Type
12.2.3. By Modality
12.2.4. By End User
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Product Type
12.3.3. By Modality
12.3.4. By End User
12.4. Key Takeaways
13. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
13.2.1. By Country
13.2.1.1. China
13.2.1.2. Japan
13.2.1.3. South Korea
13.2.2. By Product Type
13.2.3. By Modality
13.2.4. By End User
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Product Type
13.3.3. By Modality
13.3.4. By End User
13.4. Key Takeaways
14. Oceania Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
14.2.1. By Country
14.2.1.1. Australia
14.2.1.2. New Zealand
14.2.2. By Product Type
14.2.3. By Modality
14.2.4. By End User
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Product Type
14.3.3. By Modality
14.3.4. By End User
14.4. Key Takeaways
15. MEA Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
15.2.1. By Country
15.2.1.1. GCC Countries
15.2.1.2. South Africa
15.2.1.3. Israel
15.2.1.4. Rest of MEA
15.2.2. By Product Type
15.2.3. By Modality
15.2.4. By End User
15.3. Market Attractiveness Analysis
15.3.1. By Country
15.3.2. By Product Type
15.3.3. By Modality
15.3.4. By End User
15.4. Key Takeaways
16. Key Countries Market Analysis
16.1. USA
16.1.1. Pricing Analysis
16.1.2. Market Share Analysis, 2022
16.1.2.1. By Product Type
16.1.2.2. By Modality
16.1.2.3. By End User
16.2. Canada
16.2.1. Pricing Analysis
16.2.2. Market Share Analysis, 2022
16.2.2.1. By Product Type
16.2.2.2. By Modality
16.2.2.3. By End User
16.3. Brazil
16.3.1. Pricing Analysis
16.3.2. Market Share Analysis, 2022
16.3.2.1. By Product Type
16.3.2.2. By Modality
16.3.2.3. By End User
16.4. Mexico
16.4.1. Pricing Analysis
16.4.2. Market Share Analysis, 2022
16.4.2.1. By Product Type
16.4.2.2. By Modality
16.4.2.3. By End User
16.5. Germany
16.5.1. Pricing Analysis
16.5.2. Market Share Analysis, 2022
16.5.2.1. By Product Type
16.5.2.2. By Modality
16.5.2.3. By End User
16.6. United Kingdom
16.6.1. Pricing Analysis
16.6.2. Market Share Analysis, 2022
16.6.2.1. By Product Type
16.6.2.2. By Modality
16.6.2.3. By End User
16.7. France
16.7.1. Pricing Analysis
16.7.2. Market Share Analysis, 2022
16.7.2.1. By Product Type
16.7.2.2. By Modality
16.7.2.3. By End User
16.8. Spain
16.8.1. Pricing Analysis
16.8.2. Market Share Analysis, 2022
16.8.2.1. By Product Type
16.8.2.2. By Modality
16.8.2.3. By End User
16.9. Italy
16.9.1. Pricing Analysis
16.9.2. Market Share Analysis, 2022
16.9.2.1. By Product Type
16.9.2.2. By Modality
16.9.2.3. By End User
16.10. India
16.10.1. Pricing Analysis
16.10.2. Market Share Analysis, 2022
16.10.2.1. By Product Type
16.10.2.2. By Modality
16.10.2.3. By End User
16.11. Malaysia
16.11.1. Pricing Analysis
16.11.2. Market Share Analysis, 2022
16.11.2.1. By Product Type
16.11.2.2. By Modality
16.11.2.3. By End User
16.12. Singapore
16.12.1. Pricing Analysis
16.12.2. Market Share Analysis, 2022
16.12.2.1. By Product Type
16.12.2.2. By Modality
16.12.2.3. By End User
16.13. Thailand
16.13.1. Pricing Analysis
16.13.2. Market Share Analysis, 2022
16.13.2.1. By Product Type
16.13.2.2. By Modality
16.13.2.3. By End User
16.14. China
16.14.1. Pricing Analysis
16.14.2. Market Share Analysis, 2022
16.14.2.1. By Product Type
16.14.2.2. By Modality
16.14.2.3. By End User
16.15. Japan
16.15.1. Pricing Analysis
16.15.2. Market Share Analysis, 2022
16.15.2.1. By Product Type
16.15.2.2. By Modality
16.15.2.3. By End User
16.16. South Korea
16.16.1. Pricing Analysis
16.16.2. Market Share Analysis, 2022
16.16.2.1. By Product Type
16.16.2.2. By Modality
16.16.2.3. By End User
16.17. Australia
16.17.1. Pricing Analysis
16.17.2. Market Share Analysis, 2022
16.17.2.1. By Product Type
16.17.2.2. By Modality
16.17.2.3. By End User
16.18. New Zealand
16.18.1. Pricing Analysis
16.18.2. Market Share Analysis, 2022
16.18.2.1. By Product Type
16.18.2.2. By Modality
16.18.2.3. By End User
16.19. GCC Countries
16.19.1. Pricing Analysis
16.19.2. Market Share Analysis, 2022
16.19.2.1. By Product Type
16.19.2.2. By Modality
16.19.2.3. By End User
16.20. South Africa
16.20.1. Pricing Analysis
16.20.2. Market Share Analysis, 2022
16.20.2.1. By Product Type
16.20.2.2. By Modality
16.20.2.3. By End User
16.21. Israel
16.21.1. Pricing Analysis
16.21.2. Market Share Analysis, 2022
16.21.2.1. By Product Type
16.21.2.2. By Modality
16.21.2.3. By End User
17. Market Structure Analysis
17.1. Competition Dashboard
17.2. Competition Benchmarking
17.3. Market Share Analysis of Top Players
17.3.1. By Regional
17.3.2. By Product Type
17.3.3. By Modality
17.3.4. By End User
18. Competition Analysis
18.1. Competition Deep Dive
18.1.1. GE Healthcare
18.1.1.1. Overview
18.1.1.2. Product Portfolio
18.1.1.3. Profitability by Market Segments
18.1.1.4. Sales Footprint
18.1.1.5. Strategy Overview
18.1.1.5.1. Marketing Strategy
18.1.2. Natus Medical Incorporated
18.1.2.1. Overview
18.1.2.2. Product Portfolio
18.1.2.3. Profitability by Market Segments
18.1.2.4. Sales Footprint
18.1.2.5. Strategy Overview
18.1.2.5.1. Marketing Strategy
18.1.3. Inspiration Healthcare Group Plc.
18.1.3.1. Overview
18.1.3.2. Product Portfolio
18.1.3.3. Profitability by Market Segments
18.1.3.4. Sales Footprint
18.1.3.5. Strategy Overview
18.1.3.5.1. Marketing Strategy
18.1.4. Koninklijke Philips N.V.
18.1.4.1. Overview
18.1.4.2. Product Portfolio
18.1.4.3. Profitability by Market Segments
18.1.4.4. Sales Footprint
18.1.4.5. Strategy Overview
18.1.4.5.1. Marketing Strategy
18.1.5. Dragerwerk AG & Co. KGaA
18.1.5.1. Overview
18.1.5.2. Product Portfolio
18.1.5.3. Profitability by Market Segments
18.1.5.4. Sales Footprint
18.1.5.5. Strategy Overview
18.1.5.5.1. Marketing Strategy
18.1.6. Fisher & Paykel Healthcare
18.1.6.1. Overview
18.1.6.2. Product Portfolio
18.1.6.3. Profitability by Market Segments
18.1.6.4. Sales Footprint
18.1.6.5. Strategy Overview
18.1.6.5.1. Marketing Strategy
18.1.7. International Biomedical, Ltd.
18.1.7.1. Overview
18.1.7.2. Product Portfolio
18.1.7.3. Profitability by Market Segments
18.1.7.4. Sales Footprint
18.1.7.5. Strategy Overview
18.1.7.5.1. Marketing Strategy
18.1.8. Atom Medical Corporation
18.1.8.1. Overview
18.1.8.2. Product Portfolio
18.1.8.3. Profitability by Market Segments
18.1.8.4. Sales Footprint
18.1.8.5. Strategy Overview
18.1.8.5.1. Marketing Strategy
18.1.9. Fanem Ltda
18.1.9.1. Overview
18.1.9.2. Product Portfolio
18.1.9.3. Profitability by Market Segments
18.1.9.4. Sales Footprint
18.1.9.5. Strategy Overview
18.1.9.5.1. Marketing Strategy
18.1.10. Novos Medical Systems
18.1.10.1. Overview
18.1.10.2. Product Portfolio
18.1.10.3. Profitability by Market Segments
18.1.10.4. Sales Footprint
18.1.10.5. Strategy Overview
18.1.10.5.1. Marketing Strategy
18.1.11. Pluss Advanced Technologies Pvt. Ltd.
18.1.11.1. Overview
18.1.11.2. Product Portfolio
18.1.11.3. Profitability by Market Segments
18.1.11.4. Sales Footprint
18.1.11.5. Strategy Overview
18.1.11.5.1. Marketing Strategy
18.1.12. Weyer GmbH
18.1.12.1. Overview
18.1.12.2. Product Portfolio
18.1.12.3. Profitability by Market Segments
18.1.12.4. Sales Footprint
18.1.12.5. Strategy Overview
18.1.12.5.1. Marketing Strategy
19. Assumptions & Acronyms Used
20. Research Methodology
Explore Healthcare Insights
View Reports
Neonatal Thermoregulation Market
